• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童及青年期慢性肾脏病-矿物质和骨异常:逐渐深入的认识

Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.

作者信息

Lalayiannis Alexander D, Soeiro Emilia M D, Moysés Rosa M A, Shroff Rukshana

机构信息

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

University College London Great Ormond Street Hospital Institute of Child Health, London, UK.

出版信息

Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.

DOI:10.1007/s00467-023-06109-3
PMID:37624528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10817832/
Abstract

Chronic kidney disease (CKD) mineral and bone disorder (MBD) comprises a triad of biochemical abnormalities (of calcium, phosphate, parathyroid hormone and vitamin D), bone abnormalities (turnover, mineralization and growth) and extra-skeletal calcification. Mineral dysregulation leads to bone demineralization causing bone pain and an increased fracture risk compared to healthy peers. Vascular calcification, with hydroxyapatite deposition in the vessel wall, is a part of the CKD-MBD spectrum and, in turn, leads to vascular stiffness, left ventricular hypertrophy and a very high cardiovascular mortality risk. While the growing bone requires calcium, excess calcium can deposit in the vessels, such that the intake of calcium, calcium- containing medications and high calcium dialysate need to be carefully regulated. Normal physiological bone mineralization continues into the third decade of life, many years beyond the rapid growth in childhood and adolescence, implying that skeletal calcium requirements are much higher in younger people compared to the elderly. Much of the research into the link between bone (de)mineralization and vascular calcification in CKD has been performed in older adults and these data must not be extrapolated to children or younger adults. In this article, we explore the physiological changes in bone turnover and mineralization in children and young adults, the pathophysiology of mineral bone disease in CKD and a potential link between bone demineralization and vascular calcification.

摘要

慢性肾脏病(CKD)-矿物质与骨异常(MBD)包括一组生化异常(钙、磷、甲状旁腺激素和维生素D)、骨异常(骨转换、矿化和生长)以及骨骼外钙化。矿物质调节异常会导致骨脱矿,与健康同龄人相比,会引起骨痛并增加骨折风险。血管钙化,即血管壁中存在羟基磷灰石沉积,是CKD-MBD范围的一部分,进而导致血管僵硬、左心室肥厚以及极高的心血管死亡风险。虽然生长中的骨骼需要钙,但过量的钙会沉积在血管中,因此需要仔细调节钙的摄入量、含钙药物的使用以及高钙透析液的使用。正常的生理性骨矿化会持续到生命的第三个十年,这比儿童和青少年时期的快速生长要晚很多年,这意味着年轻人的骨骼钙需求量比老年人高得多。关于CKD中骨(脱)矿化与血管钙化之间联系的许多研究都是在老年人中进行的,这些数据不能外推至儿童或年轻人。在本文中,我们探讨了儿童和年轻人骨转换和矿化的生理变化、CKD中矿骨疾病的病理生理学以及骨脱矿化与血管钙化之间的潜在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/0ce028e1bf0c/467_2023_6109_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/7f0aa5538cac/467_2023_6109_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/5d5e0266e3d7/467_2023_6109_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/0ce028e1bf0c/467_2023_6109_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/7f0aa5538cac/467_2023_6109_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/5d5e0266e3d7/467_2023_6109_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/10817832/0ce028e1bf0c/467_2023_6109_Fig2_HTML.jpg

相似文献

1
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.儿童及青年期慢性肾脏病-矿物质和骨异常:逐渐深入的认识
Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.
2
The demise of calcium-based phosphate binders-is this appropriate for children?钙基磷酸盐结合剂的淘汰——这对儿童合适吗?
Pediatr Nephrol. 2015 Dec;30(12):2061-71. doi: 10.1007/s00467-014-3017-y. Epub 2014 Dec 28.
3
Role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder: A narrative review.营养性维生素 D 在慢性肾脏病-矿物质和骨异常中的作用:叙述性综述。
Medicine (Baltimore). 2023 Apr 7;102(14):e33477. doi: 10.1097/MD.0000000000033477.
4
Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.肝素钠对慢性肾脏病大鼠肾性骨营养不良和血管钙化的影响。
Bone. 2014 Jan;58:168-76. doi: 10.1016/j.bone.2013.10.010. Epub 2013 Oct 18.
5
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].[血管钙化——病理机制与临床应用——. 慢性肾脏病 - 矿物质和骨异常(CKD-MBD)中的血管钙化]
Clin Calcium. 2015 May;25(5):645-53.
6
Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.CKD-MBD 相关血管钙化的机制研究及临床意义。
Life Sci. 2022 Dec 15;311(Pt B):121148. doi: 10.1016/j.lfs.2022.121148. Epub 2022 Nov 3.
7
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.慢性肾脏病患者的骨质疏松症:系统评价。
Int J Mol Sci. 2020 Sep 18;21(18):6846. doi: 10.3390/ijms21186846.
8
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].慢性肾脏病患者骨质疏松症的诊断与治疗:奥地利骨与矿物质研究学会(ÖGKM)、奥地利物理与康复医学学会(ÖGPMR)及奥地利肾脏病学会(ÖGN)联合指南
Wien Med Wochenschr. 2023 Oct;173(13-14):299-318. doi: 10.1007/s10354-022-00989-0. Epub 2022 Dec 21.
9
Chronic kidney disease: mineral and bone disorder in children.儿童慢性肾脏病:矿物质和骨代谢紊乱。
Semin Nephrol. 2013 Mar;33(2):169-79. doi: 10.1016/j.semnephrol.2012.12.017.
10
Bone Disease in Chronic Kidney Disease and Kidney Transplant.慢性肾脏病和肾移植中的骨骼疾病
Nutrients. 2022 Dec 29;15(1):167. doi: 10.3390/nu15010167.

引用本文的文献

1
DOMINÓ Registry: study protocol on mineral and bone disease (DOença MINeral e Óssea) of chronic kidney disease in pediatrics in Brazil.多米诺注册研究:巴西儿童慢性肾脏病矿物质和骨疾病(DOença MINeral e Óssea)的研究方案
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240054. doi: 10.1590/2175-8239-JBN-2024-0054en.
2
Timing and Modality of Kidney Replacement Therapy in Children and Adolescents.儿童及青少年肾脏替代治疗的时机与方式
Kidney Int Rep. 2024 Jun 12;9(9):2750-2758. doi: 10.1016/j.ekir.2024.06.009. eCollection 2024 Sep.
3
Safety and Efficacy of Cinacalcet in Children Aged Under 3 Years on Maintenance Dialysis.

本文引用的文献

1
Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on Dialysis.慢性肾脏病4至5期或接受透析的儿童及青年的骨矿物质密度与血管钙化
Kidney Int Rep. 2022 Nov 2;8(2):265-273. doi: 10.1016/j.ekir.2022.10.023. eCollection 2023 Feb.
2
Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker.慢性肾脏病-矿物质与骨异常的进展显示了骨细胞蛋白的作用、骨-血管矛盾的潜在机制、一个治疗靶点及一种生物标志物。
Front Physiol. 2023 Jan 26;14:1120308. doi: 10.3389/fphys.2023.1120308. eCollection 2023.
3
西那卡塞对3岁以下维持性透析儿童的安全性和有效性
Kidney Int Rep. 2024 May 7;9(7):2096-2109. doi: 10.1016/j.ekir.2024.04.061. eCollection 2024 Jul.
4
Hemodiafiltration for children with stage 5 chronic kidney disease: technical aspects and outcomes.血液透析滤过治疗 5 期慢性肾脏病儿童:技术方面和结果。
Pediatr Nephrol. 2024 Sep;39(9):2611-2626. doi: 10.1007/s00467-024-06285-w. Epub 2024 Feb 13.
Macrophages and Bone Remodeling.
巨噬细胞与骨重建。
J Bone Miner Res. 2023 Mar;38(3):359-369. doi: 10.1002/jbmr.4773. Epub 2023 Feb 3.
4
Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease.天然稳定的钙同位素比值是慢性肾脏病骨钙平衡的新型生物标志物。
Kidney Int. 2022 Sep;102(3):613-623. doi: 10.1016/j.kint.2022.04.024. Epub 2022 May 27.
5
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis.患有慢性肾病及接受透析治疗的儿童和年轻人的亚临床心血管疾病负担。
Clin Kidney J. 2021 Sep 14;15(2):287-294. doi: 10.1093/ckj/sfab168. eCollection 2022 Feb.
6
The emerging role of magnesium in CKD.镁在慢性肾脏病中的新作用。
Clin Exp Nephrol. 2022 May;26(5):379-384. doi: 10.1007/s10157-022-02182-4. Epub 2022 Jan 25.
7
Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease.肠道微生物群、骨健康与慢性肾脏病血管钙化的相互作用。
Eur J Clin Invest. 2021 Sep;51(9):e13588. doi: 10.1111/eci.13588. Epub 2021 Jun 7.
8
Association between serum indoxyl sulfate levels with carotid-femoral pulse wave velocity in patients with chronic kidney disease.血清硫酸吲哚酚水平与慢性肾脏病患者颈动脉-股动脉脉搏波速度的关系。
Ren Fail. 2021 Dec;43(1):796-802. doi: 10.1080/0886022X.2021.1921797.
9
Pcresol and Indoxyl Sulfate Impair Osteogenic Differentiation by Triggering Mesenchymal Stem Cell Senescence.对甲酚和吲哚硫酸酯通过触发间充质干细胞衰老来损害成骨分化。
Int J Med Sci. 2021 Jan 1;18(3):744-755. doi: 10.7150/ijms.48492. eCollection 2021.
10
An update on vascular calcification and potential therapeutics.血管钙化的最新研究进展及潜在治疗策略。
Mol Biol Rep. 2021 Jan;48(1):887-896. doi: 10.1007/s11033-020-06086-y. Epub 2021 Jan 4.